Import alert · FDA Import Alerts (Industry 54)

Xian Lyphar Biotech Co Ltd: FDA Import Alert 66-71 (Sep 14, 2016)

Agency action: Sep 14, 2016Record ID: 66-71|Xian Lyphar Biotech Co Ltd|2016-09-14
View official source ↗

What happened

Original notice title

"Detention Without Physical Examination of Unapproved Human Growth Hormone (HGH)"

From the archived source record

"Detention Without Physical Examination of Unapproved Human Growth Hormone (HGH)". Firm/address: Xian Lyphar Biotech Co Ltd Date Published : 09/14/2016 Tang NO 11 , Yan Rd Hi Tech; Ind Zone , Xian, CHINA

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Active/current Red List snapshot
Source checked
Jul 16, 2026
Record revision
3578a6ca2360

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Human Growth Hormone (HGH); Somapacitan-beco; Somatropin
Company
Xian Lyphar Biotech Co Ltd
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.